Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Year range
1.
Chinese journal of integrative medicine ; (12): 116-122, 2014.
Article in English | WPRIM | ID: wpr-293288

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the neuro-protective effects of baicalin in Wistar rats with focal cerebral ischemic reperfusion injury.</p><p><b>METHODS</b>Ninety adult male Wistar rats weighing 320-350 g were randomly divided into the following groups (n=5): (a) sham control group; (b) vehicle group, subjected to middle cerebral artery occlusion and received vehicle intraperitoneally; (c-e) baicalin groups, which were subjected to the middle cerebral artery occlusion and treated with baicalin 25, 50 and 100 mg/kg, respectively. The neurological scores were determined at postoperative 1, 3 and 7 d after the treatment. The expression of protease-activated receptor-1 (PAR-1), PAR-1 mRNA and Caspase-3 were determined using Western blot, reverse transcription polymerase chain reaction (RTPCR) analysis and immunohistochemistry, respectively.</p><p><b>RESULTS</b>Significant decrease was noted in the neurological score in the baicalin group compared with that of the vehicle group (P<0.01). Additionally, down-regulation of PAR-1 mRNA, PAR-1 and Caspase-3 was observed in the baicalin groups compared with those obtained from the vehicle group (P<0.01). Compared with the low-dose baicalin group (25 mg/kg), remarkable decrease was noted in neurological score, and the expression of PAR-1 mRNA, PAR-1 as well as Caspase-3 in the high-dose group (P<0.05).</p><p><b>CONCLUSION</b>Baicalin showed neuro-protective effects in focal cerebral ischemic reperfusion injury through inhibiting the expression of PAR-1 and apoptosis.</p>


Subject(s)
Animals , Male , Rats , Apoptosis , Brain Ischemia , Drug Therapy , Genetics , Pathology , Caspase 3 , Metabolism , Flavonoids , Pharmacology , Therapeutic Uses , Gene Expression Regulation , RNA, Messenger , Genetics , Metabolism , Rats, Wistar , Receptor, PAR-1 , Genetics , Metabolism , Reperfusion Injury , Drug Therapy , Genetics , Pathology
2.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 814-818, 2007.
Article in Chinese | WPRIM | ID: wpr-245635

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the protective effect and mechanism of Naoningkang Granule (NG), a Chinese medicinal preparation formulated for clearing heat and detoxication, on brain tissue in intracerebral hemorrhagic (ICH) rats.</p><p><b>METHODS</b>Rats were randomly divided into 5 groups: the sham operated group, the model group and the high-, medium- and low-dose NG groups. Collagenase VII was injected into caudate nucleus to induce rat model of ICH, corresponding dosage of NG was started to give to the 3 NG groups by gastrogavage 2 h after modeling, and saline of equal volume was given to the other 2 groups instead. The brain tissue of rats was taken in batches at the 3rd and 7th day for pathomorphological observation using HE stain, and detection of thrombin receptor-1 (PAR-1) expression and nerve cell apoptosis in the peripheral tissue of hemorrhagic brain with immunohistochemistry and TUNEL assay, as well as for measurement of water content in brain tissue by wet-to-dry weight method.</p><p><b>RESULTS</b>PAR-1 expression elevated in the model rats. As compared with the model group, the pathomorphological changes significantly improved, PAR-1 expression decreased, apoptotic cells re-duced and brain edema alleviated in the 3 NG groups.</p><p><b>CONCLUSION</b>Overexpression of PAR-1 in the brain tissue might mediate the nerve cell apoptosis and brain edema in ICH rats. The mechanism of NG in protecting hemor-rhagic brain tissue might be related with its actions in inhibiting the post-cerebral high PAR-1 expression to re-duce cell apoptosis and relieve brain edema.</p>


Subject(s)
Animals , Male , Rats , Apoptosis , Brain , Metabolism , Brain Edema , Cerebral Hemorrhage , Drug Therapy , Metabolism , Pathology , Drugs, Chinese Herbal , Therapeutic Uses , Neurons , Metabolism , Pathology , Neuroprotective Agents , Therapeutic Uses , Phytotherapy , Random Allocation , Rats, Wistar , Receptor, PAR-1
3.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 691-695, 2005.
Article in Chinese | WPRIM | ID: wpr-269924

ABSTRACT

<p><b>OBJECTIVE</b>To explore the effect of Fuzheng Jiangnian Capsule (FZJN) on the pre-thrombosis correlated factors in patients with coronary heart disease (CHD).</p><p><b>METHODS</b>Ninety patients with CHD complicated with blood hyperviscosity syndrome were treated with conventional treatment and randomly divided into three groups by the additional treatment, i. e. the FZJN group (FZJN, a preparation with action of invigorating Pi, supplementing Shen, and activating blood circulation), the CSDP group [Compound Salviae droplet pill, CSDP) with the action of activating blood circulation to remove blood stasis) and the aspirin (ASP) group, 30 patients in each group. After two months of treatment, clinical efficacy, the levels of endothelin (ET), nitric oxide (NO), coagulation factor I (Fib), D-dimer (DD), thrombocytic granule membranous glucoprotein (CD62p), superoxide dismutase (SOD), high- and low-density lipoprotein-cholesterol (HDL-C, LDL-C) in patients before and after treatment were observed and compared with those in the healthy control group.</p><p><b>RESULTS</b>Compared with the healthy control group, the levels of Fib, DD, ET, CD62p were significantly higher, NO and SOD significantly lower (P<0.05, P<0.01) in all the patients with CHD. Compared with the same group before treatment, the levels of Fib, DD, ET, CD62p, LDL-C in the FZJN group lowered significantly, while NO and SOD raised significantly (P <0.05, P <0.01). ET and CD62p in the CSDP group lowered significantly, while SOD raised significantly (P < 0.05), CD62p in the ASP group lowered significantly (P < 0.05). No statistical difference was found in comparison of DD or ET, though certain improvement was shown. The total effective rate in relieving TCM syndromes and angina pectoris, and the decrease or stop rate of nitrate esters medication were superior in FZJN group to those in the CSDP group and the ASP group, respectively (P <0.05). The rate of electrocardiogram improvement in the FZJN and CSDP group was superior to that in the ASP group (P< 0.05).</p><p><b>CONCLUSION</b>Increase of Fib, DD, ET, CD62p, and decrease of NO and SOD levels were found in patients with CHD in prethrombosis stage. Compared with ASP, compound Chinese medicinal herbs can act on the prethrombosis manner of CHD patients through multi-paths, multi-links. FZJN showed better efficacy in improving correlated blood molecule markers and clinical syndromes than CSDP, suggesting that the possible mechanism of FZJN might be related to its actions in dilating blood vessels, improving microcirculation, alleviating endothelial cell damage, inhibiting activity of blood platelet, regulating coagulation-fibrolysis balance, improving metabolism of free radicals as well as lowering the level of LDL-C.</p>


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Angina, Unstable , Drug Therapy , Blood Viscosity , Capsules , Coronary Disease , Drug Therapy , Coronary Thrombosis , Drugs, Chinese Herbal , Therapeutic Uses , Medicine, Chinese Traditional , Phytotherapy , Platelet Activation , Platelet Aggregation Inhibitors , Therapeutic Uses , Vasodilator Agents , Therapeutic Uses
4.
Chinese Journal of Plastic Surgery ; (6): 87-89, 2005.
Article in Chinese | WPRIM | ID: wpr-255100

ABSTRACT

<p><b>OBJECTIVE</b>To improve the technique of prominent malar complex reduction.</p><p><b>METHODS</b>The improvements of the operation procedure included double-oblique osteotomy of the prominent malar complex, accessorial tiny preauricular incision and the way that the complex was moved upward, inward or posteriorly. The zygomatic body was fixed with microplate screw or steelwire. The jugal soft tissue was lifted to prevent facial slack. The method was used in 17 cases from June 2000 to April 2004.</p><p><b>RESULTS</b>Postoperative follow up for 4 approximately 24 months showed satisfactory result in all the cases.</p><p><b>CONCLUSIONS</b>This modified method resolved some problems in reduction malarplasty through an intraoral approach.</p>


Subject(s)
Adult , Female , Humans , Male , Young Adult , Osteotomy , Methods , Plastic Surgery Procedures , Methods , Treatment Outcome , Zygoma , General Surgery
SELECTION OF CITATIONS
SEARCH DETAIL